BB Biotech AG Performance
The entity owns a Beta (Systematic Risk) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BB Biotech are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, BB Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Quick Ratio | 15.64 | |
| Fifty Two Week Low | 62.50 | |
| Fifty Two Week High | 300.00 | |
| Trailing Annual Dividend Yield | 4.37% |
BBAGF |
BB Biotech Relative Risk vs. Return Landscape
If you would invest (100.00) in BB Biotech AG on October 21, 2025 and sell it today you would earn a total of 100.00 from holding BB Biotech AG or generate -100.0% return on investment over 90 days. BB Biotech AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc etfs are less volatile than BBAGF, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BB Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BB Biotech's investment risk. Standard deviation is the most common way to measure market volatility of otc etfs, such as BB Biotech AG, and traders can use it to determine the average amount a BB Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BBAGF |
Based on monthly moving average BB Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BB Biotech by adding BB Biotech to a well-diversified portfolio.
BB Biotech Fundamentals Growth
BBAGF OTC Etf prices reflect investors' perceptions of the future prospects and financial health of BB Biotech, and BB Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BBAGF OTC Etf performance.
| Return On Equity | 22.81 | |||
| Return On Asset | 13.35 | |||
| Profit Margin | 92.94 % | |||
| Operating Margin | 93.29 % | |||
| Current Valuation | 720.35 M | |||
| Shares Outstanding | 55.4 M | |||
| Price To Earning | 5.21 X | |||
| Price To Book | 1.19 X | |||
| Price To Sales | 7.30 X | |||
| Revenue | 866.98 M | |||
| Cash And Equivalents | 4.09 B | |||
| Cash Per Share | 73.87 X | |||
| Total Debt | 248 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 69.19 X | |||
| Cash Flow From Operations | 190.44 M | |||
| Earnings Per Share | 15.81 X | |||
| BB Biotech AG is not yet fully synchronised with the market data | |
| BB Biotech AG has some characteristics of a very speculative penny stock | |
| BB Biotech AG has a very high chance of going through financial distress in the upcoming years |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc etf could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the BB Biotech AG information on this page should be used as a complementary analysis to other BB Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in BBAGF OTC Etf
If you are still planning to invest in BB Biotech AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BB Biotech's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |